🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT02478853
Active, not recruiting Observational

Impact of a Regional Program Agir Sur Sa SantE

NCT02478853 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2015-03
Last updated
2024-12-09

Condition(s) studied

Diabetes Mellitus, Type 2ObesityHypertensionDyslipidemiasCardiovascular DiseasesSmoking

Investigational drug(s) / intervention(s)

Implementation of a new regional care framework

Implementation of a new regional care framework: Integrated care framework for the prevention and management of cardio-metabolic chronic diseases in primary care

Study summary

The prevention and control of lifestyle-related non-communicable chronic diseases, including diabetes, obesity and cardiovascular disorders, that share common risk factors, has now become a major focus of the World Health Organization. Lifestyle modification, like improvement of diet, physical activity and tobacco cessation, is the corner stone of diabetes and cardio-metabolic chronic diseases (CMCD) prevention and management. Under the leadership of decision-makers of our regional health Agency in order to improve accessibility and quality of care, our team has collaborated to the development and implementation of an integrated care framework for the prevention and management of cardio-metabolic chronic diseases in primary care. This new care framework is currently being implemented in the context of community health centers (fall 2014) and family medicine groups (spring 2015), with the support of a Quebec Ministry of Health grant. The current research proposal aims to evaluate the implementation of this new care framework and explore its impact in the primary care context. This project is very important as it will generate knowledge on new models of care integrating preventive and management interventions in primary care settings, in continuum with specialized health care services and their implementation in an entire region.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Healthcare professionals involved in CMCD management in the targeted clinics * Eligible patients should have at least one CMCD (diabetes, pre-diabetes, obesity, cardio- or cerebrovascular disease, hypertension, dyslipidemia) or be active smokers. Exclusion Criteria: * Patients who are not able to fill out questionnaires with help

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Centre de recherche du CHUS Sherbrooke Quebec

More Université de Sherbrooke trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02478853 on ClinicalTrials.gov ↗ ← All trials in Canada